Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

NCT00256685 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

568

Enrollment

INDUSTRY

Sponsor class

Conditions

Menopause
Hot Flashes
Sleep Disorders

Interventions

DRUG: DVS-233 SR

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer